scholarly journals Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review

2019 ◽  
Vol 179 (11) ◽  
pp. 2292-2306 ◽  
Author(s):  
Janna Boer ◽  
Erik Boot ◽  
Lissa Gils ◽  
Therese Amelsvoort ◽  
Janneke Zinkstok
Keyword(s):  
Systematic Review ◽  
Adverse Effects ◽  
Antipsychotic Medication ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion

Antipsychotic Treatment of 22q11.2 Deletion Syndrome-Related Psychoses

2017 ◽  
Vol 50 (04) ◽  
pp. 162-163 ◽  
Author(s):  
Elias Angelopoulos ◽  
Christos Theleritis ◽  
Marina Economou ◽  
Korina Georgatou ◽  
Charalambos Papageorgiou ◽  
...  
Keyword(s):  
Antipsychotic Medication ◽  
Combination Treatment ◽  
Pharmacological Treatment ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
Antipsychotic Treatment ◽  
Treatment Resistant ◽  
22Q11.2 Deletion ◽  
Recent Letter ◽  
Letter To The Editor

AbstractIn the recent study by Verhoeven and Egger, 2015 and the recent letter to the editor by Boot et al. 2015 an emphasis is given to the best possible pharmacological treatment of 22q11-2 Deletion-Syndrome related psychoses. We would like to present the case of a 23-year old Cypriot patient with 22q11.2 deletion syndrome who fulfilled criteria for treatment resistant schizophrenia (TRS). He was sequentially treated with aripiprazole, risperidone, olanzapine, haloperidol and a combination treatment with olanzapine and haloperidol. Clozapine was the only antipsychotic medication that has improved his condition.

scholarly journals Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder

2017 ◽  
Vol 9 (2) ◽  
pp. 54-56
Author(s):  
Candace B. Borders ◽  
Amanda Suzuki ◽  
David Safani
Keyword(s):  
Risk Factor ◽  
Panic Disorder ◽  
Adverse Effects ◽  
Late Onset ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion ◽  
Psychiatric Illnesses ◽  
Increased Risk

22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects - particularly, seizures. In this case, we discuss a 34-year-old patient presenting with late onset schizophrenia, which ultimately led to her diagnosis of 22q11DS. Subsequent management of the patient's psychosis with asenapine was complicated by concurrent anxiety and panic disorder; thus, we examine the role of anxiolytic therapy in conjunction with antipsychotics in this patient population.

Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review

2017 ◽  
Vol 176 (10) ◽  
pp. 2104-2120 ◽  
Author(s):  
Jelle F. Homans ◽  
Isabel N. Tromp ◽  
Dino Colo ◽  
Tom P. C. Schlösser ◽  
Moyo C. Kruyt ◽  
...  
Keyword(s):  
Systematic Review ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion

scholarly journals Treatment of 22q11.2 deletion syndrome-associated schizophrenia with comorbid anxiety and panic disorder

2017 ◽  
Vol 9 (2) ◽  
Author(s):  
Candace B. Borders ◽  
Amanda Suzuki ◽  
David Safani
Keyword(s):  
Risk Factor ◽  
Panic Disorder ◽  
Adverse Effects ◽  
Late Onset ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
22Q11.2 Deletion ◽  
Psychiatric Illnesses ◽  
Increased Risk

22q11.2 deletion syndrome (22q11DS) is a risk factor for psychiatric illnesses, including schizophrenia and anxiety. Small studies have shown that several neuroleptic medications are effective in treating psychosis in this population, but are also associated with an increased risk of adverse effects - particularly, seizures. In this case, we discuss a 34-year-old patient presenting with late onset schizophrenia, which ultimately led to her diagnosis of 22q11DS. Subsequent management of the patient’s psychosis with asenapine was complicated by concurrent anxiety and panic disorder; thus, we examine the role of anxiolytic therapy in conjunction with antipsychotics in this patient population.

Brain microstructural abnormalities in 22q11.2 deletion syndrome: A systematic review of diffusion tensor imaging studies

2021 ◽  
Vol 52 ◽  
pp. 96-135
Author(s):  
Sara Momtazmanesh ◽  
Mohammad Hadi Aarabi ◽  
Hossein Sanjari Moghaddam ◽  
Farnaz Delavari ◽  
Mahdieh Shafie ◽  
...  
Keyword(s):  
Systematic Review ◽  
Diffusion Tensor Imaging ◽  
Diffusion Tensor ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
Imaging Studies ◽  
22Q11.2 Deletion

scholarly journals S176. SYSTEMATIC REVIEW AND META-ANALYSIS OF MAGNETIC RESONANCE IMAGING FINDINGS IN 22Q11.2 DELETION SYNDROME

2018 ◽  
Vol 44 (suppl_1) ◽  
pp. S393-S393
Author(s):  
Guido Maria Lattanzi ◽  
Cristina Scarpazza ◽  
Fabio Di Fabio ◽  
Philip McGuire ◽  
Giuseppe Sartori ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Systematic Review ◽  
Magnetic Resonance ◽  
Meta Analysis ◽  
22Q11.2 Deletion Syndrome ◽  
Deletion Syndrome ◽  
Imaging Findings ◽  
Resonance Imaging ◽  
22Q11.2 Deletion
Sign in / Sign up

Export Citation Format

Share Document